Healthcare & Life Sciences
Passage Bio
United Stateswww.passagebio.com
Passage Bio is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Passage Bio
Passage Bio is a company headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Passage Bio is a clinical-stage gene therapy company focused on developing treatments for monogenic central nervous system diseases.
Explore Passage Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.